Northrop Boosts 2025 Profit Forecast
By Reuters | 21 Oct, 2025
Despite a downward sales revision on supply-chain fallouts from Trump's trade war, the defense giant raised its profit forecast for the second straight quarter.
Northrop Grumman raised its 2025 profit forecast for a second straight quarter on Tuesday, as the defense contractor expects continued demand for its weapons and military aircraft.
Conflicts in the Middle East and a protracted Russia-Ukraine war have prompted a surge in demand for missiles and fighter jets, boosting sales at defense contractors.
However, the impact of the Trump administration's trade war on an already-strained supply chain has pressured production in multiple industries, including defense, and suppressed the ability of businesses to execute on their backlogs.
Northrop trimmed its full-year 2025 sales outlook. It now expects between $41.7 billion and $41.9 billion, compared with its previous forecast of $42.05 billion-$42.25 billion.
Shares of the company fell 2.2% in premarket trading.
The company is also expected to compete on contracts for U.S. President Donald Trump's marquee $175 billion Golden Dome missile defense system, which could drive sales going forward.
Northrop, which makes B-2 Spirit stealth bombers used in U.S. strikes on Iran's nuclear sites earlier this year, said it now expects 2025 adjusted profit between $25.65 and $26.05 per share, up from its prior forecast of between $25.00 and $25.40 per share.
The defense giant's total revenue rose 4% to $10.42 billion in the third quarter.
It reported net income of $1.1 billion, or a per-share profit of $7.67, compared with $1.03 billion, or $7.00 per share, a year ago.
(Reporting by Utkarsh Shetti in Bengaluru and Mike Stone in Washington; Editing by Saumyadeb Chakrabarty)
Recent Articles
- Vietnamese Fishermen Faced Down KKK Violence
- 2026 Looks Big for Quantum Computing Real-World Deployment
- Xi Uses Call with Saudi Crown Prince to Step into Strait of Hormuz Conflict
- How Don Can Leave a Very Cool and Smart Legacy After All
- Samsung SDI Inks EV Battery Deal with Mercedes-Benz
- Psychedelic Drug Developer Shares Soar on Expedited FDA Approval
- Tesla's Energy Storage Division to Offset Weak EV Margins
- Jamie Dimon, Big Banks Grumble at Uneven Impact of New Bank Capital Rules
- Hormuz Shipping Reverts to Near Standstill
- Homebuilders Face Another Gloomy Year As War Adds to Hardships
